Dresden, Germany

Abgelika Rostock

This inventor holds 1 USPTO granted patent. Top assignee: Arzneimittelwerk Dresden Gmbh. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Abgelika Rostock. Retrieved from https://idiyas.com/inventor/abgelika-rostock

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Abgelika Rostock: Innovator in Antiepileptic Compounds

Introduction

Abgelika Rostock is a notable inventor based in Dresden, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiepileptic compounds. His work has the potential to impact the treatment of epilepsy and related conditions.

Latest Patents

Abgelika Rostock holds 1 patent for his invention titled "4-amino-1-arylpyridin-2-ones and process for making." This patent focuses on antiepileptic compounds characterized by specific chemical formulas, which include various residues and cardinal numbers. The compounds are designed for use as anticonvulsives, showcasing Rostock's commitment to advancing medical science.

Career Highlights

Throughout his career, Rostock has been associated with Arzneimittelwerk Dresden GmbH, where he has contributed to the development of innovative pharmaceutical solutions. His expertise in chemistry and pharmacology has positioned him as a valuable asset in the industry.

Collaborations

Rostock has worked alongside esteemed colleagues such as Hans-Joachim Lankau and Klaus Unverferth. Their collaborative efforts have furthered research and development in the field of antiepileptic medications.

Conclusion

Abgelika Rostock's contributions to the pharmaceutical industry, particularly in antiepileptic compounds, highlight his innovative spirit and dedication to improving patient care. His work continues to inspire advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…